however , at most 1-2 % of the binding inhibitor detected in human whole blood serum is related to epidermal growth factor -- the remaining consists of other factors released during preparation of serum , predominantly the platelet-derived growth factor , which are capable of altering the binding properties of the epidermal growth factor receptor .
C0086418
human
C0242275
epidermal growth factor